| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.2 | 0.0002 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.16 | 0.0003 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |